Viruses such as HPV (human papilloma virus) can cause persistent infections with oncogenic characteristics that evolve into dysplasia. Current therapies are often unable to eradicate the infections, and this can lead to abnormal or even malignant cell development. Libera Biotech is revolutionising the current therapeutic framework with nanotechnology-based antiviral treatments that are effective in treating and protecting against this type of infection.

An innovative formulation and production process, based in particular on plant-derived nanovesicles: natural containers of highly effective antioxidants. In essence, plant-derived nanovesicles are bioactive agents capable of acting on the mechanisms of cell degeneration.

Nanovesicles are obtained from plants by means of physical separation and concentration processes, which yield a nano-concentrate that contains 100% of the active ingredient found in the plant of origin. The format of the resulting phytocomplex is immediately bioavailable. At Libera Biotech it is nature that inspires science, and it is this special characteristic that makes it naturally innovative.